Gender differences in melanoma prognostic factors

Jessica Mounessa Farahi, Melissa Fazzari, Taylor Braunberger, Joseph V. Caravaglio, Alexandra Kretowicz, Keith Wells, Robert P. Dellavalle, David Norris, Theodore Alkousakis

Research output: Contribution to journalArticle

Abstract

Background: Although previous studies identify gender differences in melanoma, limited research on the phenomenon exists. Methods: In this retrospective chart review, 1,156 adults diagnosed with melanoma, between 2006-2016, at the University of Colorado were included. Breslow depth, mitotic rate, ulceration status, and location were extracted from charts between March and August 2016. Cochran-Armitage trend tests and cumulative logistic regression were used to examine the association between gender and Breslow depth, univariately and after adjusting for potential confounders. Results: In univariate analysis, males were significantly more likely to present with lesions with higher Breslow depths (p for trend=0.005). In models adjusted for age, melanoma subtype, and location, males were marginally more likely to present with lesions with higher Breslow depths (cumulative OR: 1.261, 95% CI: 0.988-1.611, p=0.060). Males were also marginally more likely to present with lesions with higher mitotic rates, after further adjustments for all other prognostic factors (cumulative OR: 1.244, 95% CI: 0.979-1.580, p=0.074). Limitations: This was a retrospective single-institution study. Conclusion: Differences in mitotic rates among melanomas in males versus females, even after adjustments for all other prognostic factors, suggests that biological differences may contribute to the female prognosis advantage.

Original languageEnglish (US)
Article number2
JournalDermatology Online Journal
Volume24
Issue number4
StatePublished - Apr 2018
Externally publishedYes

Fingerprint

Melanoma
Logistic Models
Research

Keywords

  • Breslow depth
  • Gender
  • Malignant melanoma
  • Metastasis
  • Mitotic rate
  • Prognosis
  • Ulceration

ASJC Scopus subject areas

  • Dermatology

Cite this

Farahi, J. M., Fazzari, M., Braunberger, T., Caravaglio, J. V., Kretowicz, A., Wells, K., ... Alkousakis, T. (2018). Gender differences in melanoma prognostic factors. Dermatology Online Journal, 24(4), [2].

Gender differences in melanoma prognostic factors. / Farahi, Jessica Mounessa; Fazzari, Melissa; Braunberger, Taylor; Caravaglio, Joseph V.; Kretowicz, Alexandra; Wells, Keith; Dellavalle, Robert P.; Norris, David; Alkousakis, Theodore.

In: Dermatology Online Journal, Vol. 24, No. 4, 2, 04.2018.

Research output: Contribution to journalArticle

Farahi, JM, Fazzari, M, Braunberger, T, Caravaglio, JV, Kretowicz, A, Wells, K, Dellavalle, RP, Norris, D & Alkousakis, T 2018, 'Gender differences in melanoma prognostic factors', Dermatology Online Journal, vol. 24, no. 4, 2.
Farahi JM, Fazzari M, Braunberger T, Caravaglio JV, Kretowicz A, Wells K et al. Gender differences in melanoma prognostic factors. Dermatology Online Journal. 2018 Apr;24(4). 2.
Farahi, Jessica Mounessa ; Fazzari, Melissa ; Braunberger, Taylor ; Caravaglio, Joseph V. ; Kretowicz, Alexandra ; Wells, Keith ; Dellavalle, Robert P. ; Norris, David ; Alkousakis, Theodore. / Gender differences in melanoma prognostic factors. In: Dermatology Online Journal. 2018 ; Vol. 24, No. 4.
@article{df4ea7e1b8fe48fdacdf808e74651482,
title = "Gender differences in melanoma prognostic factors",
abstract = "Background: Although previous studies identify gender differences in melanoma, limited research on the phenomenon exists. Methods: In this retrospective chart review, 1,156 adults diagnosed with melanoma, between 2006-2016, at the University of Colorado were included. Breslow depth, mitotic rate, ulceration status, and location were extracted from charts between March and August 2016. Cochran-Armitage trend tests and cumulative logistic regression were used to examine the association between gender and Breslow depth, univariately and after adjusting for potential confounders. Results: In univariate analysis, males were significantly more likely to present with lesions with higher Breslow depths (p for trend=0.005). In models adjusted for age, melanoma subtype, and location, males were marginally more likely to present with lesions with higher Breslow depths (cumulative OR: 1.261, 95{\%} CI: 0.988-1.611, p=0.060). Males were also marginally more likely to present with lesions with higher mitotic rates, after further adjustments for all other prognostic factors (cumulative OR: 1.244, 95{\%} CI: 0.979-1.580, p=0.074). Limitations: This was a retrospective single-institution study. Conclusion: Differences in mitotic rates among melanomas in males versus females, even after adjustments for all other prognostic factors, suggests that biological differences may contribute to the female prognosis advantage.",
keywords = "Breslow depth, Gender, Malignant melanoma, Metastasis, Mitotic rate, Prognosis, Ulceration",
author = "Farahi, {Jessica Mounessa} and Melissa Fazzari and Taylor Braunberger and Caravaglio, {Joseph V.} and Alexandra Kretowicz and Keith Wells and Dellavalle, {Robert P.} and David Norris and Theodore Alkousakis",
year = "2018",
month = "4",
language = "English (US)",
volume = "24",
journal = "Dermatology Online Journal",
issn = "1087-2108",
publisher = "Department of Dermatology UC Davis",
number = "4",

}

TY - JOUR

T1 - Gender differences in melanoma prognostic factors

AU - Farahi, Jessica Mounessa

AU - Fazzari, Melissa

AU - Braunberger, Taylor

AU - Caravaglio, Joseph V.

AU - Kretowicz, Alexandra

AU - Wells, Keith

AU - Dellavalle, Robert P.

AU - Norris, David

AU - Alkousakis, Theodore

PY - 2018/4

Y1 - 2018/4

N2 - Background: Although previous studies identify gender differences in melanoma, limited research on the phenomenon exists. Methods: In this retrospective chart review, 1,156 adults diagnosed with melanoma, between 2006-2016, at the University of Colorado were included. Breslow depth, mitotic rate, ulceration status, and location were extracted from charts between March and August 2016. Cochran-Armitage trend tests and cumulative logistic regression were used to examine the association between gender and Breslow depth, univariately and after adjusting for potential confounders. Results: In univariate analysis, males were significantly more likely to present with lesions with higher Breslow depths (p for trend=0.005). In models adjusted for age, melanoma subtype, and location, males were marginally more likely to present with lesions with higher Breslow depths (cumulative OR: 1.261, 95% CI: 0.988-1.611, p=0.060). Males were also marginally more likely to present with lesions with higher mitotic rates, after further adjustments for all other prognostic factors (cumulative OR: 1.244, 95% CI: 0.979-1.580, p=0.074). Limitations: This was a retrospective single-institution study. Conclusion: Differences in mitotic rates among melanomas in males versus females, even after adjustments for all other prognostic factors, suggests that biological differences may contribute to the female prognosis advantage.

AB - Background: Although previous studies identify gender differences in melanoma, limited research on the phenomenon exists. Methods: In this retrospective chart review, 1,156 adults diagnosed with melanoma, between 2006-2016, at the University of Colorado were included. Breslow depth, mitotic rate, ulceration status, and location were extracted from charts between March and August 2016. Cochran-Armitage trend tests and cumulative logistic regression were used to examine the association between gender and Breslow depth, univariately and after adjusting for potential confounders. Results: In univariate analysis, males were significantly more likely to present with lesions with higher Breslow depths (p for trend=0.005). In models adjusted for age, melanoma subtype, and location, males were marginally more likely to present with lesions with higher Breslow depths (cumulative OR: 1.261, 95% CI: 0.988-1.611, p=0.060). Males were also marginally more likely to present with lesions with higher mitotic rates, after further adjustments for all other prognostic factors (cumulative OR: 1.244, 95% CI: 0.979-1.580, p=0.074). Limitations: This was a retrospective single-institution study. Conclusion: Differences in mitotic rates among melanomas in males versus females, even after adjustments for all other prognostic factors, suggests that biological differences may contribute to the female prognosis advantage.

KW - Breslow depth

KW - Gender

KW - Malignant melanoma

KW - Metastasis

KW - Mitotic rate

KW - Prognosis

KW - Ulceration

UR - http://www.scopus.com/inward/record.url?scp=85048720184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048720184&partnerID=8YFLogxK

M3 - Article

C2 - 29905998

AN - SCOPUS:85048720184

VL - 24

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 4

M1 - 2

ER -